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ABSTRACT 
 
The Role of CYP2A5 in Cadmium-Induced Liver Injury 
by  
Julia Salamat 
 
Cadmium is present in food and groundwater. Tobacco smoking and occupational exposure are 
also major sources for cadmium. Cadmium is primarily accumulated in liver, a major organ 
metabolizing exogenous chemicals. Chemical metabolism may cause detoxification, but it can 
also cause bio-activation resulting in liver damage. Cytochrome P450s (CYP) are major liver 
metabolism enzymes, and cadmium chloride (CdCl2) can induce CYP2A5 in mice. We examined 
the effect of CYP2A5 on CdCl2-induced liver injury using CYP2A5-knockout (cyp2a5-/-) mice. 
The cyp2a5-/- mice and their control WT mice were injected CdCl2 intraperitoneally at 5 mg/kg 
body weight, respectively, to induce liver injury. The control group of cyp2a5-/- mice and WT 
mice were injected saline at the same volume. Twenty-four hours later, all the mice were 
sacrificed. As indicated by biochemical assays and pathological evaluation, CdCl2-treated WT 
mice exhibited more severe liver injury than CdCl2-treated cyp2a5-/- mice, suggesting that 
CYP2A5 contributes to Cd-induced liver injury. 
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CHAPTER 1 
 
INTRODUCTION 
 
 
Cadmium is an extremely toxic heavy metal classified as a Group 1 human carcinogen by 
the International Agency for Research on Cancer (WHO 1997). Cadmium is present in 
groundwater and soil at low levels, but through bioaccumulation, cadmium levels in tobacco 
plants, crops and rice may increase dramatically. An average person ingests about 10-40 µg 
cadmium a day from just food and water, and 1-3 µg remains in the body. A single cigarette 
contains 1-2 µg of cadmium, and a smoker has double the amount of cadmium retained in the 
body compared to non-smokers (Cupertino et al. 2013). In addition, Cd can also be obtained 
from occupational exposure, such as in batteries, paint, and plastic (Wang et al. 2014). Cadmium 
has a half-life of about thirty years and is not easily eliminated from the body, due to slow 
excretion (Dumkova et al. 2016). The liver is the primary organ that accumulates cadmium, 
followed by the kidney. While chronic cadmium exposure affects kidney the most, acute 
exposure to this heavy metal has the most effect on the liver (Baba et al. 2014). This heavy metal 
is also known to target other organs such as the testes, bones, and the cardiovascular system 
(Messner et al. 2016). 
Soil heavy metals are positively associated with obesity, diabetes, and fatty liver disease. 
One mouse study showed that cadmium exposure in water altered liver genes associated with 
lipid metabolism, cell death and survival regulatory pathways, and mitochondrial oxidative 
phosphorylation (Go et al. 2015). A cross sectional study in the Taiwanese population showed 
that soil heavy metal exposure (such as arsenic, cadmium, mercury, and lead) is associated with 
fatty liver disease (Lin et al. 2017).  In a more recent study, the presence of cadmium in maternal 
blood during pregnancy is associated with increased risk of juvenile obesity in the offspring, and 
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adiposity is increased in the zebra fish developed from those larvae that were exposed to 
cadmium (Green et al. 2018). Exposure to cadmium leads to lipid accumulation in the liver, 
which can eventually lead to the development of non-alcoholic fatty liver disease (Tinkov et al. 
2017).  
Liver is the main organ involved in metabolizing exogenous chemicals and 
detoxification. The cytochrome P450 enzymes (CYPs) serve as terminal oxidases in the mixed-
function oxidase system for metabolizing various endogenous substrates and xenobiotics, 
including drugs, toxins, and carcinogens (Lamsa et al. 2010; Pan et al. 2016). CYPs can be found 
in all biological organisms and are the most essential group involved in Phase  I metabolism (Li 
et al. 2008). All CYP450 enzymes have a heme-binding core (Hasemann et al. 1995). Members 
of the human CYP enzymes play a vital role in oxidation of a myriad of compounds originating 
both internally and externally. The enzymes are designated CYP for the superfamily cytochrome 
P450, followed by a number designating the family of the gene (greater than 40% identity on 
amino acid sequence level), a capital letter representing the subfamily (greater than 55% 
identity), and lastly a numeral denoting the individual gene in the subfamily (Lewis et al. 1998). 
Many different compounds of diverse structures can be metabolized by CYPs. A major function 
of CYP-catalyzed reactions is to convert a compound into a more polar metabolite through 
various processes such as oxidation, hydrolysis, and hydroxylation so that they can be easily 
excreted. However, for some compounds such as carbon tetrachloride or acetaminophen, 
metabolism by CYP2E1 can give rise to toxic metabolites which damage cells (Lu and 
Cederbaum 2008). 
CYP2A6 enzymes are part of the CYPs that metabolize specific potentially toxic 
compounds including some drugs, nicotine, coumarin, and procarcinogens e.g. aflatoxin B1 and 
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nitrosamines (Pelkonen et al. 1997). CYP2A6 can bio-activate tobacco specific carcinogen called 
Nicotine-derived Nitrosamine Ketone (NNK) and this contributes to tobacco smoke-induced 
carcinogenesis (Xue et al. 2014). Aflatoxin B1 is metabolized by CYP2A6 to a genotoxic 
metabolite and a role in hepato-carcinogenesis has been suggested. CYP2A6 also activates N-
nitrosamines to genotoxic intermediates (Lin et al. 2016). Additionally, CYP2A6 expression is 
increased in patients with alcoholic or non-alcoholic fatty liver. CYP2A5 is the mouse 
orthologue of human CYP2A6 (Abu-Bakar et al. 2012).  Mouse CYPA5 and human CYP2A6 
have an 86% amino acid sequence similarity (Honkakoski and Negishi 1997). Several studies 
have suggested that CYP2A5 is a useful indicator for carcinogenesis in the liver (Lamsa et al. 
2010). It was reported that an increased expression of this enzyme was observed in bacterial, 
viral, and parasitic hepatitis (Kirby et al. 1994) and a more recent study also suggested that 
CYP2A5/A6 acts as catalysts in oxidizing the compound bilirubin, therefore suggesting that 
these enzymes have a role in heme homeostasis in cells (Abu-Bakar et al. 2011). In relation to 
this, Heme Oxygenase-1 (HO-1), a protein that can also be induced by oxidative stress, 
metabolizes heme to biliverdin (Emerson and Levine 2008). HO-1 breaks down heme into 
products such as biliverdin and ferrous iron. Biliverdin would then be converted to bilirubin, a 
powerful antioxidant. However, excess production of heme, and therefore excess formation of 
bilirubin in the body can potentially be cytotoxic (Stocker et al. 1987). 
Alcohol feeding induced CYP2A5 in mice, and alcohol induced fatty-liver disease was 
enhanced in CYP2A5 knockout (cyp2a5-/-) mice suggesting that CYP2A5 protects against 
alcoholic fatty liver disease (Lu et al. 2012). CYP2A5 is also suggested to work in regulation of 
lipid metabolism and that CYP2A5 protects against high fat diet-induced metabolic syndrome 
since obesity and hepatic steatosis was more severe in cyp2a5-/- mice than their wildtype 
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counterpart (Wang et al. 2018). A study by Hong et al. 2015, also showed that CYP2A5 
prevented liver injury and fibrosis when mice were injected with thioacetamide, an organosulfur 
hepatotoxicant.  
In both the mice and humans, CYP2A5/A6 enzymes are distinctive among the other 
members of the CYP enzymes as both are stimulated by varied, unrelated substrates (Abu-Bakar 
et al. 2012). Among the conditions that induce CYP2A5 expression, the most common factor 
present is oxidative stress i.e. generating reactive oxygen species (ROS), one of the fundamental 
processes for chemical toxicity, chronic inflammation and carcinogenesis (Abu-Bakar et al. 
2012). Oxidative stress pertains to the disproportion resulting from excess ROS or oxidants 
produced over the cell’s capacity to initiate an antioxidant response to counteract the ROS. ROS 
can originate exogenously or endogenously. Externally, it can be acquired from environmental 
pollutants, drugs, and radiation. However, the majority of ROS in living organisms originates 
intracellularly during mitochondrial oxidative metabolism from the electron transport chain, as 
well as in cellular reactions to foreign substances, cytokines, bacterial invasion, as well as in 
photosynthetic processes (Nemmiche et al. 2007; Ray et al. 2012). ROS unselectively oxidizes 
all molecules in living organisms and can induce cell and tissue damage through several ways 
such as through lipid peroxidation, triggering DNA strand breaks, and inducing cell death 
through necrotic and apoptotic mechanisms (Mccord 2000; Li et al. 2015).  
Oxidative stress is one of the main mechanisms responsible for cadmium-induced 
toxicity to tissues and organs (Nemmiche 2017). It has been associated with cadmium-related 
development of immunotoxicity, nephrotoxicity, and carcinogenesis (Waisberg et al. 2003). 
Interestingly, the element cadmium itself is not capable of generating ROS directly, as it is not 
capable of direct production of free radicals (Nemmiche 2017). Free radicals are molecules that 
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consist of extremely reactive and unstable unpaired electrons (Finkel and Holbrook 2000). 
Elemental cadmium only has one oxidation state; thus, it is incapable of generating free radicals. 
However, it can indirectly promote the generation of ROS such as superoxide radicals, hydroxyl 
anions and hydrogen peroxide (Nemmiche 2017).  
Cadmium causes liver damage (Harstad and Klaassen 2002; Fouad et al. 2009) and some 
studies showed that cadmium can induce CYP2A5 (Abu-Bakar et al. 2004; Lu et al. 2011). This 
study aims to investigate if CYP2A5 has an effect on cadmium-induced liver injury by using 
cyp2a5-/- and their WT mice. CYP2A6 in humans and CYP2A5 in mice are mainly expressed in 
liver, making them a good animal model for studying biological function of CYP2A6.   
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CHAPTER 2 
METHODS 
 
Animals and Treatment 
 
The C57BL/6 background CYP2A5 knock-out (cyp2a5-/-) mouse colony was created by 
mating female C57BL/6 wild type (WT) mice (Charles River Laboratory) with male C57BL/6 
cyp2a5-/- mice (generously provided by Dr. Xinxin Ding). All the mice were created at Icahn 
School of Medicine at Mount Sinai (New York, NY) and were transferred to East Tennessee 
State University and housed in the Animal Facility in Brown Hall. The animal rooms are 
temperature-controlled with 12-hour light/dark cycles. The mice received humane care and all 
experiments performed were according to the criteria outlined in the Guide for the Care and Use 
of Laboratory Animals as well as the protocol approved by Mount Sinai and ETSU’s Division of 
Laboratory Animal Resources. 
Male cyp2a5-/- mice and WT mice (8-10 weeks) were administered cadmium chloride 
(CdCl2) at 5 mg/kg body weight intraperitoneally (i.p.). The control mice were injected i.p. with 
the same volume of saline.  All mice had access to their water and food ad libitum. For the time-
course study, wherein cadmium activity was observed at specific time points, the mice were 
divided into four groups of three mice each: 1 hour after injection, 3 mice were sacrificed. 
Another 3 were sacrificed 4 hours after injection, and 3 were sacrificed 8 hours after injection. 
For the role of CYP2A5 in Cd-induced liver injury study, 16 mice were divided into 4 groups of 
4 mice each: WT control, cyp2a5-/- control, cyp2a5-/- CdCl2, and WT CdCl2. 24 hours after 
injection, the mice were sacrificed by decapitation.  
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Mice were weighed before sacrificing. Blood was collected, and serum was separated to 
be used for biochemical assays. Whole liver was collected from each of the mice and were 
rapidly excised into fragments and washed with precooled saline. Liver sections collected from 
the same lobe from each mouse and were fixed in 10% formalin solution and sent to ETSU’s 
Pathology Department for paraffin embedding as follows: 
1. The tissue was rinsed in running water for 30-60 minutes. 
2. Put in 70% Alcohol for 20 minutes 
3. 85% Alcohol for 20 minutes 
4. 95% Alcohol for 20 minutes 
5. First absolute Alcohol for 15 minutes 
6. Second absolute Alcohol for 15 minutes 
7. Xylene-I as a clearing agent for 15 minutes 
8. Xylene-II for 15 minutes 
9. 60°C Paraffin-I for 15 minutes 
10. Paraffin-II for 15 min 
11. Paraffin-III for 15 min 
12. Embedding in cassettes 
 
Other liver tissue aliquots were stored at -80°C for further analyses. 
 
Homogenate 
Liver homogenates were prepared in ice-cold 0.15M potassium chloride (KCl). 
Liver histology and immunohistochemistry 
H&E staining and Immunohistochemical (IHC) staining  
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Paraffin liver blocks were cut into five-micrometer sections for haematoxylin and eosin 
(H&E) staining or IHC staining.   
IHC staining for 3-Nitrotyrosine was performed by using mouse monoclonal anti-3-NT 
antibody (Santa Cruz cat. # sc-101358, with a dilution of 1:200) followed by IHC Select 
Chemicon Histostain-Plus Kit (EMD Millipore cat. # DAB150).  Single antibody staining 
procedure was done. 
 
Biochemical assays 
 
Serum alanine aminotransferase (ALT) and Serum aspartate transaminase (AST) were 
assayed using a MaxDiscovery ALT/AST Color Endpoint Assay Kit (Purchased from Bioo 
Scientific Corp., cat. # ALT: 3460-08, AST: 5605-01) following manufacturer’s instructions. 
The serum was also used to test for hepatic thiobarbituric acid reactive substances (TBARS) as a 
marker for lipid peroxidation. Hepatic homogenates were incubated with 0.2 ml of TBARS 
reactive solution containing 15% (wt/vol) trichloroacetic acid (TCA), 0.375% (wt/vol) 
thiobarbituric acid (TBA) in 0.25 N HCl for 10 minutes in a boiling water bath. Followed by 
centrifugation at 200 rcf for 5 minutes. The resulting supernatant was used to determine the 
formation of TBARS by evaluating the absorbance at 535 nm. Tetramethoxypropane served as a 
standard.  
 
Western Blot Analysis 
 
Hepatic protein extracts from liver homogenates were subjected to protein assay to 
determine protein concentrations using a Pierce BCA Protein Assay Kit (cat. # 23225). After 
protein quantification, 20 µL per sample were separated by 10% SDS- polyacrylamide gel 
electrophoresis with PageRuler ä Prestained Protein Ladder used as protein ladder (Thermo Fisher 
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Scientific, cat. # 26616). The gel was then transferred to a 0.45µM nitrocellulose membrane (Bio-
Rad, cat. # 1620115). Membranes were blocked for 1 hour with 2% fat-free milk then incubated 
overnight with chicken monoclonal anti-CYP2A5 (dilution of 1:5000, gift from Dr. Risto Juvonen, 
Department of Pharmacology and Toxicology, University of Kuopio, Kupio, Finland) and rabbit 
polyclonal anti-HO-1 (dilution of 1:1000, Santa Cruz Biotechnology) primary antibodies. For 
testing acute effects of Cd at specific time points, Calnexin or β-actin were used as a protein 
loading control to look at the role of CYP2A5 in Cd-induced liver injury. Afterwards, membranes 
were incubated with respective peroxidase secondary antibodies (Millipore) for 1 hour. 
Chemiluminescent signals were detected by adding ECL Prime Detection chemiluminescent 
reagent (GE Healthcare, cat. # RPN2232). The bands of proteins were quantified with the 
Automated Digitizing System (ImageJ gel programs, version 1.34S; National Institutes of Health, 
Bethesda, MD). 
Statistical Analysis 
Results are expressed as mean ± standard deviation. Statistical evaluation was carried out 
by using one-way analysis of variance (ANOVA) followed by Student-Neuman-Keuls post hoc 
test. P < 0.05 was considered as statistically significant.  
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CHAPTER 3 
 
RESULTS 
 
 
Time-specific Increase in Liver Injury Markers Upon CdCl2 Administration  
Alanine aminotransferase (ALT) and aspartate amino transferase (AST) are known 
markers for liver injury. When the liver is damaged, these enzymes, which are usually housed in 
liver cells, spill into the blood stream (Huang et al. 2006). Serum ALT and AST were detected 
from blood of mice at time 0, 1, 4, and 8 hours after CdCl2 administration. The serum levels of 
ALT significantly increased after 4 hours of CdCl2 injection and further increased after 8 hours 
(Fig. 1A). The initial decrease after 1 hour of injection cannot be explained. However, the serum 
levels of AST significantly increased after 4 and 8 hours of CdCl2 injection (Fig. 1B). These 
results suggest that liver injury occurs after 4 hours of CdCl2 administration. 
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Figure 1. ¾ Liver injury increases in a time specific manner after CdCl2 administration. 
(A)Serum Alanine transaminase; (B) Serum Aspartate Transaminase. Data is represented by 
mean ± S.D.  *P < 0.05 compared to 0h time point; # P<0.05, compared with 4h.  
 
 
Expression of antioxidant enzyme HO-1 upon CdCl2 administration 
 
Western blot analysis was used to determine liver HO-1 and CYP2A5 protein levels in 
mice injected with CdCl2 and sacrificed 1, 4, or 8 hours after administration. Calnexin was used 
as loading control.  
HO-1 was undetected at time 0, and 1 hour but significantly increased after 4 hours and further 
increased after 8 hours (Fig. 2A). CYP2A5 levels did not have significant changes from time 0-8 
hours (Fig. 2B).  
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Figure 2. ¾ Liver HO-1 and CYP2A5 content. Western Blot analysis and quantification of liver 
HO-1 (A) and CYP2A5 (B). *P < 0.05 compared to previous time point. # P<0.05, compared with 
4h. Data is represented by mean ± S.D, N=3. 
 
 
 
Liver Injury Induced by CdCl2 in WT Mice Compared to cyp2a5-/- 
 
Exposure of Cd may cause the simultaneous activation of different cell death signals. 
These signals, such as apoptosis and autophagy, all culminate in necrosis (Messner et al. 2016). 
After 24 hours of CdCl2 exposure, hepatic necrosis was observed in the liver sections of both WT 
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and cyp2a5-/- exposed to CdCl2. Moreover, the WT group exhibited more severe necrotic injury 
compared to the cyp2a5-/- mice (Fig. 3A). The serum levels of ALT and AST, indicators of liver 
injury, were significantly elevated in the WT mice exposed to CdCl2 compared to the cyp2a5-/- 
counterpart (Fig. 3B). 
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Figure 3. ¾ Liver injury is minor in cyp2a5-/- compared to WT. H&E staining of liver sections at 
100x. Arrows point to necrotic area (A). The serum levels of ALT and AST (B) in CdCl2-exposed 
WT were much higher than cyp2a5-/- exposed to CdCl2. *P < 0.05 compared to Control group and 
#P<0.05 compared to WT CdCl2 group. 
 
 
Expression of antioxidant enzyme HO-1 upon CdCl2 administration in CYP2A5-/- vs.WT 
 
 
Western Blot analysis was used to determine HO-1 and CYP2A5 protein levels in mice 
sacrificed 24 hours after injection of CdCl2. b-actin was used as loading control (Fig. 4A). HO-1 
was significantly increased in both groups exposed to CdCl2 and was upregulated in the WT 
group exposed to CdCl2, although not significantly different. There was no significant difference 
in the CYP2A5 levels between WT exposed to CdCl2 and control (Fig. 4B). 
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Figure 4. ¾ Western Blot analysis of liver HO-1 and CYP2A5 in WT and cyp2a5-/- mice. (A) 
Representative bands of HO-1 and CYP2A5. (B) Quantification of HO-1 and CYP2A5.  * 
P<0.05, compared with Cont. 
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Markers of ROS  
 
Immunohistochemical staining was used to detect 3-Nitrotyrosine (3-NT), a marker of 
oxidative stress, in liver sections of both WT and cyp2a5-/- exposed to CdCl2. Mouse monoclonal 
anti-3-NT antibody was used to detect the presence of 3-Nitrotyrosine.  Although both WT and 
cyp2a5-/- groups exposed to CdCl2 showed an increase in 3-NT as exhibited by the darker 
coloration after staining, the level was higher in the cyp2a5-/- compared to the WT (Fig. 5A). 
Furthermore, the assay on Thiobarbicturic Acid Reactive Substances (TBARS), a byproduct of 
lipid peroxidation, was also evaluated in WT and cyp2a5-/- mice exposed to CdCl2. The TBARS 
levels in cyp2a5-/-, were significantly higher in both control and CdCl2 group (Fig. 5B). These 
results suggest that the presence of CYP2A5 can inhibit oxidative stress. 
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Figure 5. ¾ Markers of Oxidative Stress between WT and cyp2a5-/-. Liver oxidative stress is 
more severe in cyp2a5-/- mice than WT mice as indicated by the red arrows in IHC staining of 3-
NT in liver sections (A) and hepatic formation of TBARS (B). *P< 0.05 compared with WT. 
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CHAPTER 4 
 
DISCUSSION 
 
 
As mentioned earlier, CYP2A5 is unique in that this enzyme is induced by various 
chemicals. It is also distinctive compared to other members of the CYPs because it is both 
protective when it comes to ethanol-induced liver injury (Hong et al. 2015), thioacetamide-
induced liver damage (Hong et al. 2016), and high fat diet-induced metabolic syndrome (Wang 
et al. 2018), and detrimental because this enzyme can also activate certain substances to be 
carcinogenic, such as aflatoxin B1 and nitrosamines (Lin et al. 2016).  
It has long been known that cadmium is an extremely toxic environmental and industrial 
chemical (Wang et al. 2014). It was also proven to produce oxidative stress and immunotoxicity 
in cells under diverse experimental conditions (Liu et al. 2015). As mentioned earlier, Cd is 
capable of indirectly producing ROS and although the body is capable of getting rid of ROS 
derived from this heavy metal up to a certain degree, this still interrupts signaling processes in 
the body resulting in signaling dysfunction (Mitler 2002; Matovic et al. 2015). 
In the present study, we assessed how cadmium administration would affect specific 
markers of liver injury. We also examined whether CYP2A5 will have a role in the liver injury 
induced by this heavy metal. We hypothesized that as time increases, damage resulting from 
cadmium exposure worsens, even resulting in lipid accumulation in the liver. However, the 
presence of the enzyme CYP2A5 will protect against liver injury induced by this heavy metal. 
Recently it was found that acute exposure to a low dose of cadmium increases lipid content in 
hepatocytes isolated from cholesterol-fed mice by affecting the autophagy process (Rosales-Cruz 
et al. 2018). The in vivo study showed that mice fed with 10mg/L of cadmium in their drinking 
water for 20 weeks developed fatty liver disease. The altered genes and liver metabolites related 
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to lipid metabolism resulted in high cholesterol and triglycerides therefore caused these mice to 
accumulate fat in their liver (Go et al. 2015). 
We found that upon CdCl2 injection of 5 mg/kg body weight intraperitoneally, liver 
damage starts as soon as 4 hours after exposure as shown by hallmarks of liver damage such as 
ALT and AST. Both enzymes had a significant increase in serum 4 hours after injection and 8 
hours after injection. There was no increase in the CYP2A5 enzyme level in between time points 
as indicated by the western blot, however, the enzyme Heme Oxygenase-1 (HO-1), was 
significantly upregulated 4 and 8 hours after CdCl2 administration, suggesting that CdCl2 can 
induce this enzyme. As mentioned in the introduction, HO-1 is the enzyme in-charge of the 
degradation of heme, therefore making it unavailable for CYP450 protein to incorporate heme in 
their structure. This would then lead to the decrease of the CYP450 enzymes affecting CYP 450-
catalyzed activity (Chung et al. 2009; Karuzina and Archakov 1994). Activation of the HO-1 
gene is regulated by a transcription factor called Nuclear erythroid-related factor 2 (Nrf2) and 
Cadmium can impede the disintegration of this transcription factor, therefore, leading to 
upregulation of HO-1 (Abu-Bakar 2004). 
With the WT showing more severe liver injury than the knockouts, it seems that CYP2A5 
metabolizes CdCl2 to a more toxic metabolite, therefore promoting CdCl2-induced liver injury. 
Additionally, no abnormal lipid accumulation was witnessed in both groups exposed to CdCl2, 
instead pathological evaluation showed necrosis. Sub-micromolar quantities of this heavy metal 
might actually lead to delayed apoptosis, while high concentrations can cause necrosis (Luevano 
and Damodaran 2014). Unlike apoptosis and autophagy, necrosis is unregulated. But the 
obstruction of certain proteins involved in regulation of apoptosis or autophagy can change the 
type of cell death to necrosis (Golstein and Kroemer 2007). Although the wildtype exposed to 
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CdCl2 showed more liver damage as shown by the transaminases and by H&E staining, lipid 
peroxidation exhibited by TBARS assay and 3-NT IHC staining, was greater in CYP2A5 knock-
out, suggesting that the presence of CYP2A5 is protective against oxidative degradation of 
lipids. 
CdCl2 exposure is able to induce oxidative stress. A study by Wang et al. 2004, suggested 
that this heavy metal affects the electron transport chain of cellular respiration in the cell’s 
mitochondria. This heavy metal possibly binds between semi-ubiquinone and cytochrome b566 
of cytochrome b in Complex III, therefore resulting in buildup of semi-ubiquinone at this site. 
Semi-ubiquinones are radicals, making them highly reactive (Quinlan et al. 2012). The semi-
ubiquinone will then have an affinity to transfer one electron to molecular oxygen, forming a 
superoxide. This is a possible mechanism to how Cd can produce ROS in the mitochondria. 
However, the process of how CYP2A5 interacts with this heavy metal, as well as the role of HO-
1 have to be further investigated. As this thesis project was an acute study, it will also be 
interesting to study both enzymes under chronic exposure.  
 
 26 
REFERENCES 
 
 
Abu-Bakar A. 2004. Acute cadmium chloride administration induces hepatic and renal CYP2A5 
mRNA, protein and activity in the mouse: involvement of transcription factor NRF2. 
Toxicology Letters. 148(3):199–210. [accessed 18 Sept 2018] 
 
Abu-Bakar A, Hakkola J, Juvonen R, Rahnasto-Rilla M, Raunio H, Lang M. 2012. Function and 
Regulation of the Cyp2a5/CYP2A6 Genes in Response to Toxic Insults in the Liver. 
Current Drug Metabolism. 14(1):137-150. [accessed 13 Sept 2018] 
 
Abu-Bakar A, Arthur D, Aganovic S, Ng J, Lang M. 2011. Inducible bilirubin oxidase: A novel 
function for the mouse cytochrome P450 2A5. Toxicology and Applied Pharmacology. 
257(1): 14-22. [accessed 13 Sept 2018] 
 
Baba H, Tsuneyama K, Yazaki M, Nagata K, Minamisaka T, Tsuda T, Nomoto K, Hayashi S, 
Miwa S, Nakajima T, et al. 2013. The liver in itai-itai disease (chronic cadmium 
poisoning): pathological features and metallothionein expression. Modern Pathology. 
26(9):1228–1234. [accessed 12 Sept 2018] 
 
Chung SW, Hall S, Perrella MA. 2009. Role of heme oxygenase-1 in microbial host defense. 
Cellular Microbiology. 11(2): 199–207. [accessed 19 Sept 2018] 
 
Cupertino MC, Costa KLC, Santos DCM, Novaes RD, Condessa SS, Neves AC, Oliveira JA, 
Matta SLP. 2013. Long-lasting morphofunctional remodelling of liver parenchyma and 
stroma after a single exposure to low and moderate doses of cadmium in rats. 
International Journal of Experimental Pathology. 94(5):343–351. [accessed 12 Sept 2018] 
 
Dumkova J, Vrlikova L, Vecera Z, Putnova B, Docekal B, Mikuska P, Fictum P, Hampl A, 
Buchtova M. 2016. Inhaled Cadmium Oxide Nanoparticles: Their in Vivo Fate and Effect 
on Target Organs. International Journal of Molecular Sciences. 17(6):874. [accessed 10 
Sept 2018] 
 
Emerson MR, Levine SM. 2008. Heme Oxygenase-1 and NADPH Cytochrome P450 Reductase 
Expression in Experimental Allergic Encephalomyelitis. Journal of Neurochemistry. 
75(6):2555–2562. [accessed 16 Oct 2018] 
 
Fouad AA, Qureshi HA, Yacoubi MT, Al-Melhim WN. 2009. Protective role of carnosine in 
mice with cadmium-induced acute hepatotoxicity. Food and Chemical Toxicology. 
47(11):2863–2870. [accessed 22 Oct 2018] 
 
Finkel T, Holbrook NJ. 2000. Oxidants, oxidative stress and the biology of ageing. Nature. 
408(6809):239–247. [accessed 15 Sept 2018] 
 
 
 27 
Go Y-M, Sutliff RL, Chandler JD, Khalidur R, Kang B-Y, Anania FA, Orr M, Hao L, Fowler 
BA, Jones DP. 2015. Low-Dose Cadmium Causes Metabolic and Genetic Dysregulation 
Associated With Fatty Liver Disease in Mice. Toxicological Sciences. 147(2):524–534. 
[accessed 10 Sept 2018] 
 
Golstein P, Kroemer G. 2007. Cell death by necrosis: towards a molecular definition. Trends in 
Biochemical Sciences. 32(1):37–43. [accessed 18 Sept 2018] 
 
Green AJ, Hoyo C, Mattingly CJ, Luo Y, Tzeng J-Y, Murphy S, Planchart A. 2017.  Cadmium 
Exposure Increases The Risk Of Juvenile Obesity: A Human And Zebrafish Comparative 
Study. International Journal of Obesity, 42(7):1285–1295. [accessed 08 Oct 2018] 
 
Hasemann CA, Kurumbail RG, Boddupalli SS, Peterson JA, Deisenhofer J. 1995. Structure and 
function of cytochromes P450:a comparative analysis of three crystal structures. 
Structure. 3(1):41–62. [accessed 19 Sept 2018] 
 
Harstad EB, Klaassen CD. 2002. Tumor Necrosis Factor-α-Null Mice Are Not Resistant to 
Cadmium Chloride-Induced Hepatotoxicity. Toxicology and Applied Pharmacology. 
179(3):155–162. [accessed 22 Oct 2018] 
 
Hinson JA, Roberts DW, James LP. 2009. Mechanisms of Acetaminophen-Induced Liver 
Necrosis. Handbook of Experimental Pharmacology Adverse Drug Reactions. 196: 369–
405. [accessed 21 Sept 2018] 
 
Hong F, Liu X, Ward SS, Xiong H, Cederbaum AI, Lu Y. 2015. Absence of cytochrome P450 
2A5 enhances alcohol-induced liver injury in mice. Digestive and Liver Disease. 
47(6):470–477. [accessed 16 Sept 2018] 
 
Hong F, Si C, Gao P, Cederbaum AI, Xiong H, Lu Y. 2015. The role of CYP2A5 in liver injury 
and fibrosis: chemical-specific difference. Naunyn-Schmiedebergs Archives of 
Pharmacology. 389(1):33–43. [accessed 16 Sept 2018] 
 
Honkakoski P, Negishi M. 1997. The Structure, Function, and Regulation of Cytochrome P450 
2A Enzymes. Drug Metabolism Reviews. 29(4):977–996. [accessed 20 Sept 2018] 
 
Huang X-J, Choi Y-K, Im H-S, Yarimaga O, Yoon E, Kim H-S. 2006. Aspartate 
Aminotransferase (AST/GOT) and Alanine Aminotransferase (ALT/GPT) Detection 
Techniques. Sensors. 6(7):756–782. [accessed 09 Sept 2018] 
 
IARC (1997) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans—
Beryllium, Cadmium, Mercury, and Exposures in the Glass Manufacturing Industry. 
Summary of Data Reported and Evaluation. 58. International Agency for cancer 
Research—World Health Organisation [accessed 09 Sept 2018] 
 
Karuzina II, Archakov AI. 1994. Hydrogen peroxide-mediated inactivation of microsomal 
cytochrome P450 during monooxygenase reactions. Free Radical Biology and Medicine. 
17(6):557–567. [accessed 18 Sept 2018] 
 28 
 
Kirby GM, Chemin I, Montesano R, Chisari FV, Lang MA, Wild CP. 1994. Induction of specific 
cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic 
mice. Molecular Carcinogenesis. 11(2):74–80. [accessed 14 Sept 2018] 
 
Lämsä Virpi, Levonen A-L, Leinonen H, Ylä-Herttuala Seppo, Yamamoto M, Hakkola J. 2010. 
Cytochrome P450 2A5 Constitutive Expression and Induction by Heavy Metals Is 
Dependent on Redox-Sensitive Transcription Factor Nrf2 in Liver. Chemical Research in 
Toxicology. 23(5):977–985. [accessed 13 Sept 2018] 
 
Lewis D, Watson E, Lake B. 1998. Evolution of the cytochrome P450 superfamily: sequence 
alignments and pharmacogenetics. Mutation Research/Reviews in Mutation Research. 
410(3):245–270. [accessed 29 Oct 2018] 
 
Li L, Chang Z, Pan Z, Fu Z-Q, Wang X. 2008. Modes of heme binding and substrate access for 
cytochrome P450 CYP74A revealed by crystal structures of allene oxide synthase. 
Proceedings of the National Academy of Sciences. 105(37):13883–13888. [accessed 19 
Sept 2018] 
 
Li S, Tan H, Wang N, Zhang Z, Lao L, Wong C, Feng Y. 2015. The Role of Oxidative Stress 
and Antioxidants in Liver Diseases. International Journal of Molecular Sciences. 
16(11):26087-26124. [accessed 14 Sept 2018] 
 
Lin X, Gu Y, Zhou Q, Mao G, Zou B, Zhao J. 2016. Combined toxicity of heavy metal mixtures 
in liver cells. Journal of Applied Toxicology. 36(9):1163–1172. [accessed 14 Sept 2018] 
 
Lin Y-C, Lian I-B, Kor C-T, Chang C-C, Su P-Y, Chang W-T, Liang Y-F, Su W-W, Soon M-S. 
2017. Association between soil heavy metals and fatty liver disease in men in Taiwan: a 
cross sectional study. BMJ Open. 7(1). [accessed 15 Sept 2018] 
 
Liu L, Tao R, Huang J, He X, Qu L, Jin Y, Zhang S, Fu Z. 2015. Hepatic oxidative stress and 
inflammatory responses with cadmium exposure in male mice. Environmental 
Toxicology and Pharmacology. 39(1):229–236. [accessed 17 Sept 2018] 
 
Loomba R, Sanyal AJ. 2013. The global NAFLD epidemic. Nature Reviews Gastroenterology & 
Hepatology. 10(11):686–690. [accessed 10 Sept 2018] 
 
Lu Y, Cederbaum AI. 2008. CYP2E1 and oxidative liver injury by alcohol. Free Radical Biology 
and Medicine. 44(5):723–738. [accessed 08 Oct 2018] 
 
Lu Y, Zhang XH, Cederbaum AI. 2012. Ethanol Induction of CYP2A5: Role of CYP2E1-ROS-
Nrf2 Pathway. Toxicological Sciences. 128(2):427–438. [accessed 13 Sept 2018] 
 
Lu Y, Zhuge J, Wu D, Cederbaum AI. 2010. Ethanol Induction of CYP2A5: Permissive Role for 
CYP2E1. Drug Metabolism and Disposition. 39(2):330–336. [accessed 08 Oct 2018] 
 
 29 
Luevano J, Damodaran C. 2014. A Review of Molecular Events of Cadmium-Induced 
Carcinogenesis. Journal of Environmental Pathology, Toxicology and Oncology. 
33(3):183–194. [accessed 15 Sept 2018] 
 
Matović V, Buha A, Ðukić-Ćosić D, Bulat Z. 2015. Insight into the oxidative stress induced by 
lead and/or cadmium in blood, liver and kidneys. Food and Chemical Toxicology. 
78:130–140. [accessed 15 Sept 2018] 
 
Mccord JM. 2000. The evolution of free radicals and oxidative stress. The American Journal of 
Medicine, 108(8): 652-659. [accessed 15 Sept 2018] 
 
Messner B, Ploner C, Laufer G, Bernhard D. 2012. Cadmium activates a programmed, lysosomal 
membrane permeabilization-dependent necrosis pathway. Toxicology Letters. 
212(3):268–275. [accessed 18 Sept 2018] 
 
Messner B, Türkcan A, Ploner C, Laufer G, Bernhard D. 2015. Cadmium overkill: autophagy, 
apoptosis and necrosis signalling in endothelial cells exposed to cadmium. Cellular and 
Molecular Life Sciences. 73(8):1699–1713. [accessed 09 Sept 2018] 
 
Mittler R. (2002). Oxidative stress, antioxidants and stress tolerance. Trends in Plant Science. 
7(9):405-410. [accessed 15 Sept 2018] 
 
Montagner A, Polizzi A, Fouché E, Ducheix S, Lippi Y, Lasserre F, Barquissau V, Régnier M, 
Lukowicz C, Benhamed F, et al. 2016. Liver PPARα is crucial for whole-body fatty acid 
homeostasis and is protective against NAFLD. Gut. 65(7):1202–1214. [accessed 10 Sept 
2018] 
 
Nemmiche S. 2017. Oxidative Signaling Response to Cadmium Exposure. Toxicological 
Sciences. 156(1): 4-10. [accessed 15 Sept 2018] 
 
Nemmiche S, Chabane-Sari D, Guiraud P. 2007. Role of α-tocopherol in cadmium-induced 
oxidative stress in Wistar rats blood, liver and brain. Chemico-Biological Interactions. 
170(3):221–230. [accessed 15 Sept 2018] 
 
Pan S-T, Xue D, Li Z-L, Zhou Z-W, He Z-X, Yang Y, Yang T, Qiu J-X, Zhou S-F. 2016. 
Computational Identification of the Paralogs and Orthologs of Human Cytochrome P450 
Superfamily and the Implication in Drug Discovery. International Journal of Molecular 
Sciences. 17(7):1020. [accessed 14 Sept 2018] 
 
Pelkonen P, Lang MA, Negishi M, Wild CP, Juvonen RO. 1997. Interaction of Aflatoxin B1with 
Cytochrome P450 2A5 and Its Mutants:  Correlation with Metabolic Activation and 
Toxicity. Chemical Research in Toxicology. 10(1):85–90. [accessed 10 Sept 2018] 
 
Quinlan CL, Orr AL, Perevoshchikova IV, Treberg JR, Ackrell BA, Brand MD. 2012. 
Mitochondrial Complex II Can Generate Reactive Oxygen Species at High Rates in Both 
 30 
the Forward and Reverse Reactions. Journal of Biological Chemistry. 287(32):27255–
27264.. [accessed 22 Sept 2018] 
 
Ray PD, Huang B-W, Tsuji Y. 2012. Reactive oxygen species (ROS) homeostasis and redox 
regulation in cellular signaling. Cellular Signalling. 24(5):981–990 [accessed 15 Sept 
2018] 
 
Rosales-Cruz P, Domínguez-Pérez M, Reyes-Zárate E, Bello-Monroy O, Enríquez-Cortina C, 
Miranda-Labra R, Bucio L, Gómez-Quiroz LE, Castillo ER-D, Gutiérrez-Ruíz MC, et al. 
2018. Cadmium exposure exacerbates hyperlipidemia in cholesterol-overloaded 
hepatocytes via autophagy dysregulation. Toxicology. 398-399:41–51. [accessed 10 Sept 
2018] 
 
Stocker R, Yamamoto Y, Mcdonagh A, Glazer A, Ames B. Bilirubin is an antioxidant of 
possible physiological importance. Science. 1987;235(4792):1043–1046. [accessed 19 
Sept 2018] 
 
Su T. 2004. Regulation of the cytochrome P450 2A genes. Toxicology and Applied 
Pharmacology. 199(3): 285-294. [accessed 20 Sept 2018] 
 
Tinkov AA, Filippini T, Ajsuvakova OP, Aaseth J, Gluhcheva YG, Ivanova JM, Bjørklund G, 
Skalnaya MG, Gatiatulina ER, Popova EV, et al. 2017. The role of cadmium in obesity 
and diabetes. Science of The Total Environment. 601-602:741–755. [accessed 10 Sept 
2018] 
 
Waisberg M, Joseph P, Hale B, Beyersmann D. 2003. Molecular and cellular mechanisms of 
cadmium carcinogenesis. Toxicology. 192(2-3):95–117. [accessed 15 Sept 2018] 
 
Wang J, Zhu H, Liu X, Liu Z. 2014. N-acetylcysteine protects against cadmium-induced 
oxidative stress in rat hepatocytes. Journal of Veterinary Science. 15(4):485. [accessed 09 
Sept 2018] 
 
Wang K, Chen X, Ward SC, Liu Y, Ouedraogo Y, Xu C, Cederbaum AI, Lu Y. 2018. CYP2A6 
is associated with obesity: studies in human samples and a high fat diet mouse model. 
International Journal of Obesity. [accessed 13 Sept 2018] 
 
Wang Y. 2004. Cadmium inhibits the electron transfer chain and induces Reactive Oxygen 
Species. Free Radical Biology and Medicine. 36(11):1434–1443. [accessed 22 Sept 2018] 
 
Xue J, Yang S, Seng S. 2014. Mechanisms of Cancer Induction by Tobacco-Specific NNK and 
NNN. Cancers. 6(2): 1138–1156. [accessed 08 Oct 2018] 
  
 31 
VITA 
 
JULIA MARIE SALAMAT 
 
 
Personal Data:     Date of Birth: September 8, 1994 
 
Place of Birth: Manila, Philippines 
 
 
Education:  M.S. Biology, with a concentration in Biomedical 
Sciences, East Tennessee State University, Dec. 
2018 
 
B.S. Biology minor in Chemistry, University of 
Tennessee at Chattanooga, Dec. 2016 
 
 
Professional Experience:  Graduate Assistant, East Tennessee State 
University, Department of Biology, 2017-2018 
 
Research Assistant, East Tennessee State 
University, Department of Health Sciences, 2017-
2018 
 
 
Publications: Chen, X., Owoseni, E., Salamat, J., Cederbaum, A. 
and Lu, Y. (2018). Nicotine enhances alcoholic 
fatty liver in mice: Role of CYP2A5. Archives of 
Biochemistry and Biophysics, 657, pp.65-73. 
 
 
 
 
